Aldeyra Therapeutics stock plunges 71% after the FDA issues a third CRL for the resubmitted reproxalap NDA for the treatment of dry eye disease.
The FDA has, for a third time, declined to approve reproxalap for the treatment of dry eye disease, according to a press ...
Previously, the Company had received CRLs in November 2023 and April 2025 due to insufficient evidence in addressing the ...
Aldeyra Therapeutics Inc. (NASDAQ:ALDX) said it has received a Complete Response Letter from the U.S. Food and Drug Administration rejecting its New Drug Application for reproxalap, a proposed ...
Pharmacological options for the treatment of dry eye syndrome (DES) include both topical agents (typically the preferred form of pharmacologic treatment) and oral systemic drugs. Drugs used in topical ...
After delaying its review, the FDA has rejected Aldeyra Therapeutics’ experimental dry eye disease treatment for the third time. | After delaying its review, the FDA has rejected Aldeyra Therapeutics’ ...
Aldeyra Therapeutics Inc. ALDX shares are tumbling on Tuesday following the U.S. Food and Drug Administration (FDA) update.
Once relatively rare, dry eye disease (DED) is now considered one of the most common — and annoying — eye conditions. Here’s what you need to know about determining if you have it, identifying the ...
Jai G. Parekh, MD, MBA; and Alexander Kabiri, OD; explore the current treatment landscape of dry eye disease. This is a video synopsis/summary of a Stakeholder Summit involving: Ryan Haumschild, ...
More than 360 million people around the world suffer from dry eye disease, which is characterized by chronically red, scratchy or irritated eyes. blackday - stock.adobe.com Dry eye disease is no ...
Researchers have successfully used a new robot system to improve treatment for debilitating eye disease. Researchers from King's, with doctors at King's College Hospital NHS Foundation Trust, have ...
As we age, our eyesight inevitably changes, and so we must focus on new ways to maintain it. Older people with diabetes need to take special care of their vision ...